DLC1 and Liver Cancer: The Akt Connection

Slides:



Advertisements
Similar presentations
The Promoter of Human Telomerase Reverse Transcriptase Is Activated During Liver Regeneration and Hepatocyte Proliferation Hüseyin Sirma, Mukesh Kumar,
Advertisements

Reconstitution of Normal Hepcidin Expression in Hfe-Deficient Mice After Liver Transplantation: A New Role of HFE in Kupffer Cells?  Ivana De Domenico,
Volume 154, Issue 5, Pages (April 2018)
Myc Target miRs and Liver Cancer: Small Molecules to Get Myc Sick
Covering the Cover Gastroenterology
Volume 154, Issue 5, Pages (April 2018)
Volume 132, Issue 3, Pages (March 2007)
Volume 152, Issue 4, Pages (March 2017)
Timing Is Everything: Brca2 and p53 Mutations in Pancreatic Cancer
Christoph Lübbert, Babett Holler  Gastroenterology 
Covering the Cover Gastroenterology
Outcomes Among Living Liver Donors
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Gastroenterology 2011–2016: Looking Back and Forward
The Increasing Diversity of KRAS Signaling in Pancreatic Cancer
Clinical Challenges and Images in GI
The Changing Liver Transplant Waitlist: An Emerging Liver Purgatory?
Unusual Case of an Upset Stomach
Volume 155, Issue 4, Pages (October 2018)
Volume 135, Issue 4, Pages (October 2008)
A Historical Perspective on Clinical Advances in Pancreatic Diseases
Volume 150, Issue 4, Pages (April 2016)
Yutaka Tomizawa, Lei Zhao, Leslie W. Yang  Gastroenterology 
Sonia Radunz, Hideo A. Baba, Georgios C. Sotiropoulos  Gastroenterology 
Hepatitis C and Hepatocellular Carcinoma: Grist for the Mill
Colon Cancer: An Update and Future Directions
Volume 137, Issue 1, Pages (July 2009)
Volume 155, Issue 6, Pages (December 2018)
Covering the Cover Gastroenterology
Dosage of Atg5 Gene Affects Pancreatic Tumorigenesis and Progression
Amir Shlomai, Ana Tobar, Ofer Benjaminov  Gastroenterology 
Valerie Blanc, Nicholas O. Davidson  Gastroenterology 
Coffee and Colorectal Cancer: Grounds for Prevention?
Volume 150, Issue 5, Pages (May 2016)
Patricia Munoz-Garrido, Jesper B. Andersen  Gastroenterology 
Reduced Mortality Rates Following Elective Percutaneous Liver Biopsies
Volume 133, Issue 2, Pages (August 2007)
Volume 150, Issue 7, Pages (June 2016)
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Volume 148, Issue 3, Pages (March 2015)
Shivan J. Mehta, Kimberly A. Forde  Gastroenterology 
Timing Is Everything: Brca2 and p53 Mutations in Pancreatic Cancer
Volume 150, Issue 7, Pages (June 2016)
The Rise and Fall (and Rise?) of Endoscopic Anti-Reflux Procedures
Covering the Cover Gastroenterology
The Dawning of a New Editorial Board for Gastroenterology
Richard J. Saad, William D. Chey  Gastroenterology 
Volume 132, Issue 3, Pages (March 2007)
Volume 142, Issue 5, Pages (May 2012)
Rho GTPase and Wnt Signaling Pathways in Hepatocarcinogenesis
Volume 156, Issue 4, Pages (March 2019)
Volume 139, Issue 1, Pages (July 2010)
Changing of the Guards: 2011–2016 Gastroenterology Team
Volume 156, Issue 4, Pages (March 2019)
Volume 156, Issue 3, Pages (February 2019)
Volume 155, Issue 6, Pages (December 2018)
Esophageal Tumor After Radical Surgery for Gastric Cancer
Cancer Costs Projected to Reach at Least $158 Billion in 2020
Volume 138, Issue 6, Pages (May 2010)
End-Stage Liver Disease in 2008: Finally a Glass Half Full
Reinvesting in US Biomedical Research—The Time is Now
Covering the Cover Gastroenterology
A Rare Primary Liver Tumor That Responded to Sorafenib
Electronic Clinical Challenges and Images in GI
Controversies in Liver Transplantation for Hepatitis C
Pao-Ying Lin, Chun-Chao Chang, Jean-Dean Liu  Gastroenterology 
Covering the Cover Gastroenterology
Reconstitution of Normal Hepcidin Expression in Hfe-Deficient Mice After Liver Transplantation: A New Role of HFE in Kupffer Cells?  Ivana De Domenico,
Volume 146, Issue 4, Pages (April 2014)
A Rare Tumor of the Liver With a Sudden Presentation
Presentation transcript:

DLC1 and Liver Cancer: The Akt Connection Torsten Wuestefeld, Lars Zender  Gastroenterology  Volume 139, Issue 4, Pages 1093-1096 (October 2010) DOI: 10.1053/j.gastro.2010.08.016 Copyright © 2010 AGA Institute Terms and Conditions

Figure 1 Schematic representation of a model suggesting 2 independent tumor suppressive functions mediated by DLC1. (A) Loss of DLC1 expression through genomic deletion or promoter hypermethylation enhances hepatocarcinogenesis via increased RhoA signaling. (B) DLC1 phosphorylation by AKT can promote tumorigenesis without affecting DLC1's function as a RhoGTPase activating protein. Gastroenterology 2010 139, 1093-1096DOI: (10.1053/j.gastro.2010.08.016) Copyright © 2010 AGA Institute Terms and Conditions